Global Circulating Tumor Cells Market Size & Outlook

The circulating tumor cells industry worldwide is expected to reach a projected revenue of US$ 27,547.4 million by 2030. A compound annual growth rate of 13.3% is expected of the worldwide circulating tumor cells industry from 2024 to 2030.
Revenue, 2023 (US$M)
$11,466.8
Forecast, 2030 (US$M)
$27,547.4
CAGR, 2024 - 2030
13.3%
Report Coverage
Worldwide

Global circulating tumor cells market, 2018-2030 (US$M)

Global circulating tumor cells market highlights

  • The global circulating tumor cells market generated a revenue of USD 11,466.8 million in 2023 and is expected to reach USD 27,547.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 13.3% by 2030.
  • In terms of segment, ctc detection & enrichment methods accounted for a revenue of USD 7,592.2 million in 2023.
  • CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 11,466.8 million
Market revenue in 2030USD 27,547.4 million
Growth rate13.3% (CAGR from 2023 to 2030)
Largest segmentCtc detection & enrichment methods
Fastest growing segmentCTC Analysis
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis

Other key industry trends

  • In terms of revenue, the North America accounted for 42.3% of the global circulating tumor cells market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 19.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Circulating Tumor Cells Market Companies

Name Profile # Employees HQ Website

Global circulating tumor cells market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.


Ctc detection & enrichment methods was the largest segment with a revenue share of 66.21% in 2023. Horizon Databook has segmented the Global circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Circulating Tumor Cells Technology Outlook (Revenue, USD Million, 2018-2030)
    • CTC Detection & Enrichment Methods
      • Immunocapture (Label-based)
        • Positive Selection
        • Negative Selection
      • Size-based Separation (Label-free)
        • Membrane-based
        • Microfluidic-based
      • Density-based Separation (Label-free)
      • Combined Methods (Label-free)
    • CTC Direct Detection Methods
      • SERS
      • Microscopy
      • Others
    • CTC Analysis
  • Global Circulating Tumor Cells Application Outlook (Revenue, USD Million, 2018-2030)
    • Clinical/ Liquid Biopsy
      • Risk Assessment
      • Screening and Monitoring
    • Research
      • Cancer Stem Cell & Tumorogenesis Research
      • Drug/Therapy Development
  • Global Circulating Tumor Cells Product Outlook (Revenue, USD Million, 2018-2030)
    • Kits & Reagents
    • Blood Collection Tubes
    • Devices or Systems
  • Global Circulating Tumor Cells Specimen Outlook (Revenue, USD Million, 2018-2030)
    • Blood
    • Bone Marrow
    • Other Body Fluids

Reasons to subscribe to Global circulating tumor cells market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global circulating tumor cells market databook

  • Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global circulating tumor cells market , including forecasts for subscribers. This global databook contains high-level insights into Global circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global circulating tumor cells market size, by regions, 2018-2030 (US$M)

Top 10 countries: Circulating tumor cells market size, 2023 (US$M)

Global circulating tumor cells market share, by technology, 2023 & 2030 (%, US$M)

Circulating tumor cells market: Opportunity assessment by country

Global circulating tumor cells market, by region, 2023 (US$M)

Global circulating tumor cells market size, by regions, 2018-2030 (US$M)

Technology 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 3,403.6 3,828.8 3,618.2 3,994.5 4,392.8 4,854.2 5,390.0 6,013.6 6,741.4 7,593.2 8,592.9 9,769.9 11,160.0 12.6%
Europe 2,435.2 2,761.5 2,630.9 2,928.4 3,247.1 3,618.3 4,051.7 4,559.3 5,155.3 5,857.5 6,687.3 7,671.1 8,841.7 13.6%
Asia Pacific 1,660.9 1,900.0 1,826.1 2,050.9 2,294.7 2,580.5 2,916.3 3,312.3 3,780.7 4,336.6 4,998.6 5,789.9 6,739.0 14.7%
Latin America 194.2 215.5 200.9 218.7 237.2 258.5 282.9 311.2 343.8 381.6 425.4 476.5 536.1 11.0%
MEA 131.3 142.4 129.7 137.9 146.1 155.4 166.0 178.2 192.1 207.9 226.1 246.8 270.6 8.3%
Overall 7,825.1 8,848.2 8,405.7 9,330.4 10,317.8 11,466.8 12,806.9 14,374.5 16,213.2 18,376.7 20,930.3 23,954.2 27,547.4 13.3%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more